FDA Inspection
Eurofins BioPharma Product Testing Columbia, LLCEurofins BioPharma Product Testing Columbia, LLC – FDA Inspection, Jan 14, 2022
Record Details
This FDA Inspection record concerns Eurofins BioPharma Product Testing Columbia, LLC, with an inspection on January 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 14, 2022
- Product Type
- Drugs
View Company Profile
ID · eba63794-537e-48f1-a247-1601e534152e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1161343
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins BioPharma Product Testing Columbia, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2024 | Not classified | Kansas City District Office | |
| August 15, 2018 | Not classified | Kansas City District Office | |
| January 26, 2017 | Not classified | Kansas City District Office | |
| March 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins BioPharma Product Testing Columbia, LLC
- FDA Inspection 1258161 - 2024-12-04
- FDA Inspection 1065874 - 2018-08-15
- FDA Inspection 999122 - 2017-01-26
- FDA Inspection 917473 - 2015-03-06
- FDA Inspection 791170 - 2012-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.